MIR4764

Across TCGA pan-cancer cohorts, MIR4764 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated MIR4764 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher MIR4764 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR4764 expression acts as an unfavorable survival marker.

OV, ESCA, and PCPG are the cancer types where MIR4764 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	IV	0.022	0.760	<.001	36	view →
ESCA	OS	Tertile	IV	0.135	0.568	.031	36	view →
PCPG	OS	Tertile	All	0.010	0.946	<.001	36	view →
SKCM	DFS	Tertile	All	0.074	0.761	<.001	27	view →
STAD	DFS	Tertile	III,IV	0.351	0.515	.035	21	view →
LGG	OS	Tertile	All	0.221	0.889	<.001	18	view →
THCA	DFS	Tertile	III,IV	0.189	0.742	.021	9	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

MIR4764–OV (OS)

Open the OV breakdown →